Cyclosporine-induced parkinsonism

J Neurol. 2009 Apr;256(4):674-5. doi: 10.1007/s00415-009-0137-6. Epub 2009 Apr 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Brain / pathology
  • Carbidopa / therapeutic use
  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Fatal Outcome
  • Hematoma, Subdural / chemically induced
  • Hematoma, Subdural / pathology
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Lymphoid / therapy
  • Levodopa / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Parkinsonian Disorders / chemically induced*
  • Parkinsonian Disorders / drug therapy
  • Parkinsonian Disorders / pathology
  • Stem Cell Transplantation

Substances

  • Antiparkinson Agents
  • Immunosuppressive Agents
  • Levodopa
  • Cyclosporine
  • Carbidopa